Outcomes of Intradetrusor Onabotulinum Toxin A Therapy in Overactive Bladder Refractory to Sacral Neuromodulation

PURPOSE: Intradetrusor onabotulinum toxin A (BTXA) and sacral neuromodulation (SNM) are effective third-line therapies for overactive bladder (OAB). We aimed to measure the outcomes of BTXA for treatment of OAB refractory to initial SNM and identify patient characteristics associated with these outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Trinh, Hamilton, Irish, Vicki, Diaz, Mireya, Atiemo, Humphrey
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Continence Society 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790822/
https://www.ncbi.nlm.nih.gov/pubmed/31607102
http://dx.doi.org/10.5213/inj.1938030.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790822/
https://www.ncbi.nlm.nih.gov/pubmed/31607102
http://dx.doi.org/10.5213/inj.1938030.015

Ejemplares similares